Celsion (CLSN) Says ThermoDox Missed Primary Endpoint in Phase III HEAT

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Celsion (CLSN) Says ThermoDox Missed Primary Endpoint in Phase III HEAT

Roth Capital Downgrades Celsion Corp (CLSN) to Neutral

January 31, 2013 2:57 PM EST

Earlier, Roth Capital downgraded Celsion Corp (NASDAQ: CLSN) from Buy to Neutral with a price target of $1.70 (from $10.00) following today's trial failure.

For an analyst ratings summary and ratings history on Celsion Corp click here. For more ratings news on Celsion Corp click here.

Shares of Celsion are down 81% to $1.52.... More

Celsion (CLSN) will resume trading at 7:30AM after Trial Failure

January 31, 2013 7:27 AM EST

Celsion Corporation (NASDAQ: CLSN) will resume trading at 7:30AM ThermoDox Missed Primary Endpoint in Phase III HEAT... More

Celsion (CLSN) to Hold Phase III HEAT Call on Jan. 31; Receives Priority Trial Designation

January 30, 2013 4:15 PM EST

Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that it will host a conference call and webcast at 8:00 a.m. Eastern Time on Thursday, January 31, 2013 to present the top-line results from its pivotal Phase III HEAT Study with ThermoDox® in combination... More

Celsion (CLSN) trading halted with news pending

January 30, 2013 4:03 PM EST

Celsion Corporation (NASDAQ: CLSN) trading halted with news pending.... More